Volume 9.05 | Feb 12

ESC & iPSC News 9.05 February 12, 2014
ESC & iPSC News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  ESC & iPSC News on Twitter
 
TOP STORY
Histones May Hold the Key to the Generation of Totipotent Stem Cells
One major challenge in stem cell research has been to reprogram differentiated cells to a totipotent state. Researchers have identified a duo of histone proteins that dramatically enhance the generation of induced pluripotent stem cells and may be the key to generating induced totipotent stem cells. [Press release from RIKEN discussing online prepublication in Cell Stem Cell] Press Release | Abstract | Graphical Abstract
Directed Differentiation of Pluripotent Stem Cells - A Cell Stem Cell Poster
 
PUBLICATIONS (Ranked by impact factor of the journal)
Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages
Scientists describe a stepwise method in which pluripotency reprogramming factors were transiently expressed in fibroblasts in conjunction with a unique combination of soluble molecules to generate definitive endoderm-like cells that did not pass through a pluripotent state. The resulting pancreatic progenitor-like cells could mature into cells of all three pancreatic lineages in vivo, including functional, insulin-secreting β-like cells that help to ameliorate hyperglycemia. [Cell Stem Cell] Abstract | Graphical Abstract | Press Release

The Two Active X Chromosomes in Female ESCs Block Exit from the Pluripotent State by Modulating the ESC Signaling Network
Using embryonic stem cells with distinct sex chromosome compositions as a model system, scientists showed that two X chromosomes stabilize the naive pluripotent state by inhibiting MAPK and Gsk3 signaling and stimulating the Akt pathway. [Cell Stem Cell] Abstract | Graphical Abstract

Isolation of Single-Base Genome-Edited Human iPS Cells without Antibiotic Selection
Researchers developed an efficient method to capture rare mutational events, enabling isolation of mutant lines with single-base substitutions without antibiotic selection. This method facilitates efficient induction or reversion of mutations associated with human disease in isogenic human induced pluripotent stem cells. [Nat Methods] Abstract

Derivation and Characterization of Mouse Embryonic Stem Cells from Permissive and Nonpermissive Strains
The authors describe a protocol for efficient derivation of germline-competent mouse embryonic stem cells from any mouse strain, including strains previously deemed nonpermissive. They provide a protocol that is generally applicable to most inbred strains, as well as a variant for nonpermissive strains. [Nat Protoc] Abstract

Oct4 Is Required for Lineage Priming in the Developing Inner Cell Mass of the Mouse Blastocyst
Investigators explored the role of Oct4 in blastocyst formation and specification of epiblast versus primitive endoderm lineages using conditional genetic deletion. Experiments involving mouse embryos deficient for both maternal and zygotic Oct4 suggest that it is dispensable for zygote formation, early cleavage and activation of Nanog expression. [Development] Abstract | Full Article

Growth and Proliferation of Human Embryonic Stem Cells on Fully Synthetic Scaffolds Based on Carbon Nanotubes
Scientists showed an industrially scalable and inexpensive method of fabricating entirely synthetic, non-xenogeneic carbon nanotube-based scaffolds by vacuum filtration for the culture of human embryonic stem cells. [ACS Appl Mater Interfaces] Abstract | Press Release

ONSL and OSKM Cocktails Act Synergistically in Reprogramming Human Somatic Cells into Induced Pluripotent Stem Cells
Researchers compared the reprogramming efficiency of two different polycistronic genes, OCT4, NANOG, SOX2 and LIN28 (ONSL) and OCT4, SOX2, KLF4 and cMYC (OSKM) placed in the same retrovector backbone. [Mol Hum Reprod] Abstract

A Single-Cell and Feeder-Free Culture System for Monkey Embryonic Stem Cells
Researchers report a new single-cell and feeder-free culture system for primate pluripotent stem cells, the key feature of which is an originally formulated serum-free medium containing FGF and activin. [PLoS One]
Full Article

Win a $25 Amazon Gift Card!
Connexon Creative is evaluating reader interest in a new social media platform. Fill out this quick survey for your chance to win 1 of 4 $25 gift cards! Take survey here


Induce Neural Progenitor Cells Faster and More Effectively - Watch New Technical Video
 
REVIEWS
iPS Cells: A Game Changer for Future Medicine
Since induced pluripotent stem cells (iPSCs) can be used in micromedicine for drug discovery and in macromedicine for actual clinical trials, their use would tightly connect both micro- and macromedicine. The use of iPSCs in disease modeling, cell transplantation, and clinical trials could therefore lead to significant changes in the future of medicine. [EMBO J] Abstract

Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field.

Attend IBC Life Sciences' Biopharmaceutical Development & Production in San Diego, CA!
 
INDUSTRY NEWS
Disgraced Scientist’s Stem Cell Tech Receives US Patent
Disgraced cloning scientist Hwang Woo-suk’s controversial NT-1 “embryonic stem cell line” officially received a United States patent, in a development that could reignite debate surrounding his research. The US Patent and Trademark Office’s public notification site confirmed the “human embryonic stem cell line prepared by nuclear transfer of a human somatic cell into an enucleated human oocyte” has been patented and subject to legal protection. [BusinessKorea Co., Ltd.] Press Release

JDRF to Provide Additional Support for Upcoming Clinical Trial of ViaCyte’s Encapsulated Cell Therapy for Type 1 Diabetes
JDRF and ViaCyte, Inc. jointly announced that JDRF is providing additional milestone-based funding for the continued development of ViaCyte’s VC-01™ encapsulated cell therapy product candidate for the treatment of type 1 diabetes. [ViaCyte, Inc.] Press Release

From our sponsor:
Interested in assays for human mammary stem and progenitor cells? Request your free wallchart.
 
POLICY NEWS
Judges Side with FDA on Stem Cells
The D.C. Circuit Court of Appeals ruled that culturing a patient’s stem cells for therapeutic use falls under the aegis of the US Food and Drug Administration (FDA). FDA has said therapeutic stem cells should be regulated as drugs. [The Scientist] Editorial | Court Ruling

Stem Cell Lines Not Fit for Clinic
Many of the stem cell lines used by academics and registered with the U.S. National Institutes of Health would not be eligible for commercialization because they don’t pass muster with the Food and Drug Administration, according to a report published in Cell Stem Cell. The lack of harmonization between the agencies’ standards throws up a potential roadblock on the path from the laboratory to the clinic. [The Scientist] Editorial | Report

UK Politicians Demand Action over Dearth of Female Scientists
An influential group of UK politicians has demanded that more be done to increase the number of women in scientific careers. The House of Commons Science and Technology Select Committee points the finger at universities. [Nature News] Editorial
 
EVENTS
NEW The Stem Cell Niche 2014
May 18-22, 2014
Copenhagen, Denmark

Visit our events page to see a complete list of events in the ESC & iPSC community.
 
JOB OPPORTUNITIES
NEW Postdoctoral Fellow – Stem Cell Biology (McEwen Centre for Regenerative Medicine)

Postdoctoral Scholar – Cell-Cell Interactions in Mammalian Development (University of California, San Francisco)

Postdoctoral Fellow – Human Induced Pluripotent Stem Cell Initiative (European Bioinformatics Institute)

Senior Research Scientist – Immunogenicity and Epigenetic Regulation of hiPSC-Derived Endothelial Cells (Magdi Yacoub Institute)

Postdoctoral Position – Stem Cell Signaling and Epigenetics (Fondazione Istituto Nazionale Genetica Molecolare)

Postdoctoral Position – Systems Biology of Cellular Reprogramming (University of California, San Diego)

Postdoctoral Position – Stem Cells and Epigenetics (Mount-Sinai)

Postdoctoral Fellow – Morphogenetic Signaling Pathways in Development and Disease (University of Rochester Medical Center)

Postdoctoral Position – Epigenetic Regulation of Heart Formation Using Human ES & iPS Cells (University of Pittsburgh)


Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in ESC & iPSC News? Click here to submit!

Comments or suggestions? Submit your feedback here.
Learn more about ESC & iPSC News: Archives | Events | Contact Us